Archives
-
Cy5-UTP and Single-Molecule RNA Insight
2026-10-08
A thought-leadership perspective on how Cy5-UTP and Cyanine 5-uridine triphosphate connect direct RNA visualization with mechanistic questions about R-loops, replication stress, assay translation, and evidence quality.
-
CBD, Orofacial Pain, and Endocannabinoid Signaling
2026-10-08
A 2026 Brain Research Bulletin study reports that cannabidiol reduced acute and chronic inflammatory pain in mice while also improving pain-related affective and cognitive abnormalities. Its central contribution is a multidimensional mechanism linking peripheral CB2-associated anti-inflammatory effects, central CB1 signaling, endocannabinoid changes, and serotonin activity in the central amygdala.
-
Recombinant Annexin V and Endothelial Thrombin Formation
2026-10-07
The 1994 study by Van Heerde and colleagues examined how recombinant Annexin V binds human endothelial cells and suppresses cell-surface reactions that generate factor Xa and thrombin. Its central contribution was to connect measurable phosphatidylserine-dependent binding with inhibition of multiple coagulation complexes on a cellular, rather than artificial vesicle, surface.
-
Escitalopram in Antidepressant Research: Evidence
2026-10-07
A source-grounded overview of Escitalopram and Lexapro in serotonergic research, emphasizing mechanism, clinical evidence from ziprasidone augmentation, phenotype-specific findings, translational applications, provenance, and limitations.
-
DiscoveryProbe Natural Product Library Plus
2026-10-06
Explore how the DiscoveryProbe Natural Product Library Plus can support mechanistic natural product screening for drug discovery. This article connects the L1039P library’s chemical diversity with evidence from a Cryptosporidium parvum AdhE study while emphasizing target validation, phenotype interpretation, and translational limits.
-
Annexin V: Reading Phosphatidylserine Signals
2026-10-06
Annexin V is a calcium-dependent phosphatidylserine binding protein used to interpret membrane changes associated with apoptosis. This article moves beyond workflow advice to examine signal meaning, evidence limits, and how human recombinant Annexin V supports rigorous cell death research.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-10-05
A 2025 Nature Metabolism study identifies intestinal TM6SF2 as a protective regulator of MASH through effects on epithelial lipid handling, barrier integrity, microbial ecology and lysophosphatidic acid signaling. Its mouse-model evidence supports a gut-to-liver mechanism, while also defining important limits on translation to human disease and to CCR2-focused intervention studies.
-
ALT Cancer Cells and ATR Inhibition: What the Data Show
2026-10-05
The 2016 study by Deeg and colleagues tested whether alternative lengthening of telomeres, or ALT, broadly predicts hypersensitivity to ATR inhibition. Across diverse cancer cell models and an isogenic ALT-suppression system, the reported data did not support a general ALT-specific response to VE-821, highlighting the importance of separating telomere biology from cell-line-specific drug sensitivity.
-
Calcein AM/PI Staining: Five Evidence Questions
2026-10-04
A source-grounded overview of what Calcein AM/PI fluorescence measures, how it relates to mammalian cell viability and cytotoxicity studies, and how cautiously to interpret findings alongside preclinical evidence on gramine in triple-negative breast cancer.
-
ECL Chemiluminescent Substrate Kit: From Signal to Claim
2026-10-03
The ECL Chemiluminescent Substrate Detection Kit connects HRP-generated light with protein-level evidence in pathway research. Using syringin and sunitinib studies in renal cell carcinoma as a case study, this article explains how ECL supports interpretation without confusing signal detection with biological proof.
-
Live-Dead Cell Staining Kit I for Phototherapy
2026-10-02
Use Calcein AM/PI staining to distinguish viable mammalian cancer cells from membrane-compromised cells after hypoxia-activated phototherapy. This practical workflow adds rapid fluorescence live/dead cell detection to dose-response, light-control, and mechanism-focused experiments without mistaking membrane damage for a complete apoptosis or ferroptosis diagnosis.
-
JNJ-26481585 (Quisinostat) Assay Guide
2026-10-01
A scenario-based guide to using JNJ-26481585 (Quisinostat), SKU A4090, in cell viability, proliferation, apoptosis, and drug-resistance studies. It connects HDAC biology with practical dosing, solvent control, orthogonal readouts, and evidence-based product selection.
-
JNK-IN-7: Selective JNK Inhibitor Guide
2026-10-01
JNK-IN-7 is a selective JNK inhibitor that targets JNK1, JNK2, and JNK3 and suppresses c-Jun phosphorylation through covalent kinase engagement. Its defined biochemical profile and pathway-specific cellular effects support MAPK signaling pathway research, apoptosis assay design, and innate immune signaling modulation.
-
Annexin V-HF647/PI Apoptosis Kit in ESCC
2026-09-30
Learn how the Annexin V-HF647/PI Apoptosis Kit can translate HOXC9–AKT/mTOR biology into a rigorous apoptosis measurement strategy in esophageal squamous cell carcinoma. This guide emphasizes interpretation, controls, and assay design rather than treating fluorescence as a standalone mechanistic conclusion.
-
Live-Dead Cell Staining Kit I for Neuronal Assays
2026-09-30
Learn how Calcein AM/PI staining converts neuronal injury experiments into interpretable live, dead, and membrane-compromised cell profiles. This workflow combines practical staining parameters, image-analysis safeguards, and troubleshooting for mammalian cytotoxicity studies inspired by cerebral hemorrhage research.